No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
WST240621C340000
- 6.00
- +4.00+200.00%
15min DelayClose May 31 16:00 ET
6.00High6.00Low
6.00Open2.00Pre Close51 Volume17 Open Interest340.00Strike Price30.60KTurnover27.94%IV4.18%PremiumJun 21, 2024Expiry Date0.00Intrinsic Value100Multiplier18DDays to Expiry6.00Time Value100Contract SizeAmericanOptions Type0.3723Delta0.0179Gamma63.13Leverage Ratio-0.2293Theta0.0617Rho23.50Eff Leverage0.2865Vega
Intraday
- 5D
- 1D
News
Express News | West Pharmaceutical Announced Today That It Will Unveil Its New Daikyo Crystal Zenith Nested Vials In Tub At The International Society For Cell And Gene Therapy Annual Meeting Taking Place In Vancouver, Canada
West Introduces Daikyo Crystal Zenith® (CZ) Ready-to-Use Nested Vials in Tub at the International Society for Cell and Gene Therapy
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that it...
Express News | NYSE Order Imbalance 72550.0 Shares on Buy Side
Here's Why West Pharmaceutical Services (WST) Bounced Back in Q1
The Total Return for West Pharmaceutical Services (NYSE:WST) Investors Has Risen Faster Than Earnings Growth Over the Last Five Years
It might be of some concern to shareholders to see the West Pharmaceutical Services, Inc. (NYSE:WST) share price down 11% in the last month. But in stark contrast, the returns over the last half de
How Is The Market Feeling About West Pharmaceutical Servs?
West Pharmaceutical Servs's (NYSE:WST) short percent of float has fallen 13.37% since its last report. The company recently reported that it has 975 thousand shares sold short, which is 1.75% of all r
Comments
RECAP
U.S. equity indexes rose after Thursday, with the $Nasdaq Composite Index(.IXIC.US$ lagging the pack, as investors weighed retail sales and jobless claims ahead of more inflation data this week.
The $S&P 500 Index(.SPX.US$ rose 0.58% to 5,029, a new closing high with the $Dow Jones Industrial Average(.DJI.US$ up 0.91% to 38,664. The $Nasdaq Composite Index(.IXIC.US$ was moderately higher at 15,906, af...
U.S. equity indexes rose after Thursday, with the $Nasdaq Composite Index(.IXIC.US$ lagging the pack, as investors weighed retail sales and jobless claims ahead of more inflation data this week.
The $S&P 500 Index(.SPX.US$ rose 0.58% to 5,029, a new closing high with the $Dow Jones Industrial Average(.DJI.US$ up 0.91% to 38,664. The $Nasdaq Composite Index(.IXIC.US$ was moderately higher at 15,906, af...
41
5
Analysts worry about the company's shifting tone and the enduring effect of clients' inventory management on West's finances. Doubts also arise about the company's demand visibility and if current trends suggest a fundamental issue in West's base business.
Jefferies analyst David Windley sees FDA approvals of GLP-1s for obesity treatment as a huge opportunity for the manufacturing supply chain. He also notes high rivalry in the injectable fill/finish market. Windley upgraded West Pharmaceutical to Buy, raising its price target by 66% to $536, citing its global footprint and capacity to meet growing GLP-1s demand.
The market sentiment around West Pharmaceutical Services hasn't changed much over the past five years, with the share price seemingly reacting to the EPS. The recent improvement in TSR could indicate that the business is getting better with time.
1
The 4- and 5-star rated Dividend Aristocrats for 2024 include Abbott Laboratories, AbbVie Inc., Air Products & Chemicals, and others such as Coca-Cola Co., McDonald's Corp., Walmart Inc., and West Pharmaceuticals.
1
Read more
Qulynnitha Bowman : How much money do i need to invest in stocks
102556055 : $Futu Holdings Ltd (FUTU.US)$
Cypher : “$Microsoft(MSFT.US)$'s OpenAi released a short 60-minute video.”
The video is 60 seconds, not minutes. The writing quality on this platform has really been down lately. I’ve caught way too many errors.
bellalita : good news
Malik ritduan : oo